The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Opioid-Induced Glial Activation: Mechanisms of Activation and Implications for Opioid Analgesia, Dependence, and Reward
Open accessAbstract
This review will introduce the concept of toll-like receptor (TLR)-mediated glial activation as central to all of the following: neuropathic pain, compromised acute opioid analgesia, and unwanted opioid side effects (tolerance, dependence, and reward). Attenuation of glial activation has previously been demonstrated both to alleviate exaggerated pain states induced by experimental pain models and to reduce the development of opioid tolerance. Here we demonstrate that selective acute antagonism of TLR4 results in reversal of neuropathic pain as well as potentiation of opioid analgesia. Attenuating central nervous system glial activation was also found to reduce the development of opioid dependence, and opioid reward at a behavioral (conditioned place preference) and neurochemical (nucleus accumbens microdialysis of morphine-induced elevations in dopamine) level of analysis. Moreover, a novel antagonism of TLR4 by (+)- and (-)-isomer opioid antagonists has now been characterized, and both antiallodynic and morphine analgesia potentiating activity shown. Opioid agonists were found to also possess TLR4 agonistic activity, predictive of glial activation. Targeting glial activation is a novel and as yet clinically unexploited method for treatment of neuropathic pain. Moreover, these data indicate that attenuation of glial activation, by general or selective TLR antagonistic mechanisms, may also be a clinical method for separating the beneficial (analgesia) and unwanted (tolerance, dependence, and reward) actions of opioids, thereby improving the safety and efficacy of their use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An emerging body of evidence suggests that activated glia and glia-derived neuroinflammatory mediators play an important role in drug reward, dependence, tolerance and analgesic properties (Hutchinson et al., 2007).”
From Stress- and Glucocorticoid-Induced Priming of Neuroinflammatory Responses: Potential Mechanisms of Stress-Induced Vulnerability to Drugs of Abuse (2011) · cites this paper as Hutchinson et al., 2007
In the citing paper
“There is an emerging evidence that glia and glia-derived neuroinflammatory mediators play key roles in the development of drug abuse.”
From Stress- and Glucocorticoid-Induced Priming of Neuroinflammatory Responses: Potential Mechanisms of Stress-Induced Vulnerability to Drugs of Abuse (2011) · cites this paper as Hutchinson et al., 2007
In the citing paper
“Importantly, we have also shown that morphine and other clinically relevant opioids (oxycodone and methadone) function as TLR4 agonists using TLR4 transfected human embryonic kidney (HEK-293) cells (Hutchinson et al., 2007).”
From Stress- and Glucocorticoid-Induced Priming of Neuroinflammatory Responses: Potential Mechanisms of Stress-Induced Vulnerability to Drugs of Abuse (2011) · cites this paper as Hutchinson et al., 2007
In the citing paper
“Moreover, an overwhelming amount of evidence demonstrates that within the CNS, opioid administration leads to the activation of microglia via a toll-like receptor (TLR)-4-dependent mechanism, and produces paradoxical aggravation of proinflammatory immune responses (Hutchinson et al, 2007;Watkins et al, 2009).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Hutchinson et al, 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sindrup, S. H., & Jensen, T. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00154-2 · Cited by 1,142
Glial activation: a driving force for pathological pain
Watkins, L. R., Milligan, E. D., & Maier, S. F. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01854-3 · Cited by 1,091
Self-citationA systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramèr, M. R., Nye, B., Carroll, D., Wiffen, P. J., & Moore, A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 926
Major increases in opioid analgesic abuse in the United States: Concerns and strategies
Compton, W. M., & Volkow, N. D. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.009 · Cited by 824
Anticonvulsant drugs for management of pain: a systematic review
McQuay, H., Carroll, D., Jadad, A. R., Wiffen, P. J., & Moore, A. (1995) · BMJ · doi:10.1136/bmj.311.7012.1047 · Cited by 712
Spinal Glia and Proinflammatory Cytokines Mediate Mirror-Image Neuropathic Pain in Rats
Milligan, E. D., Twining, C. M., Chacur, M., Biedenkapp, J. C., O'Connor, K., Poole, S., Tracey, K. J., Martin, D. P., Maier, S. F., & Watkins, L. R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-03-01026.2003 · Cited by 701
Self-citationThe CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy
Tanga, F. Y., Nutile-McMenemy, N., & DeLeo, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501634102 · Cited by 634
Wybran, J., Appelboom, T., Famaey, J.-P., & Govaerts, A. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.3.1068 · Cited by 580
Why is Wallerian degeneration in the CNS so slow?
Vargas, M. E., & Barres, B. A. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094354 · Cited by 510
Vasudeva, R., Rutkowski, M. D., & DeLeo, J. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09980.2002 · Cited by 468
Flagged first, then by citations
Research works printed but not linked: 2
- Tanga, F.Y., Nutile-McMenemy, N., and Deleo, J.A. (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. U. S. A. 102(16), 5856-5861.
- Watkins, L.R., Hutchinson, M.R., Zhang, Y., Coats, B.D., Sprunger, D.B., Hughes, T.S., Maier, S.F., Johnson, K.W., and Rice, K.C. (2007) Identification and characterization of a novel opioid site of action: implications for opioid- induced glial activation. In Press: Society for Neuroscience San Diego, CA.
Cited by
Sorted by citations
Items 101–200 of 359
Loram, L. C., Grace, P. M., Strand, K. A., Taylor, F. R., Ellis, A., Berkelhammer, D. L., Bowlin, M., Skarda, B., Maier, S. F., & Watkins, L. R. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.08.003 · Cited by 53
Self-citationSex-Dependent Influences of Morphine and its Metabolites on Pain Sensitivity in the Rat
Doyle, H. H., & Murphy, A. Z. (2017) · Physiology and Behavior · doi:10.1016/j.physbeh.2017.11.030 · Cited by 47
Hook, M., Washburn, S., Moreno, G. L., Woller, S., Puga, D., Lee, K. H., & Grau, J. (2010) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2010.10.018 · Cited by 51
Opioid administration following spinal cord injury: Implications for pain and locomotor recovery
Woller, S. A., & Hook, M. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.008 · Cited by 52
Opioids and Chronic Pain: Where Is the Balance?
Davis, M. P., & Mehta, Z. Y. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0558-1 · Cited by 53
Lumbar foraminal neuropathy: an update on non-surgical management
Choi, Y. S. (2019) · The Korean journal of pain · doi:10.3344/kjp.2019.32.3.147 · Cited by 51
Postoperative cognitive dysfunction is made persistent with morphine treatment in aged rats
Muscat, S. M., Deems, N. P., D’Angelo, H. M., Kitt, M. M., Grace, P. M., Andersen, N. D., Silverman, S. N., Rice, K. C., Watkins, L. R., Maier, S. F., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.11.008 · Cited by 50
Self-citationPain management in fibromyalgia
Crofford, L. J. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282fb0268 · Cited by 50
Diagnosis and treatment of narcotic bowel syndrome
Kurlander, J. E., & Drossman, D. A. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.53 · Cited by 49
Glial neuroimmune signaling in opioid reward
Zhang, H., Largent‐Milnes, T. M., & Vanderah, T. W. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.11.012 · Cited by 50
Validation of a Preclinical Spinal Safety Model
Westin, B. D., Walker, S. M., Deumens, R., Grafe, M. R., & Yaksh, T. L. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181dcd6ec · Cited by 48
Bhave, S. M., Gade, A. R., Kang, M., Hauser, K. F., Dewey, W. L., & Akbarali, H. I. (2017) · The FASEB Journal · doi:10.1096/fj.201601068r · Cited by 48
Cooper, Z. D., Jones, J. D., & Comer, S. D. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.651123 · Cited by 47
Targeting Cytokines for Morphine Tolerance: A Narrative Review
Liu, D.-Q., Zhou, Y., & Gao, F. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171128144441 · Cited by 47
Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence
Liu, L., Hutchinson, M. R., White, J. M., Somogyi, A. A., & Coller, J. K. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328331e68f · Cited by 45
Self-citationNarcotic Bowel Syndrome and Opioid-Induced Constipation
Szigethy, E., Schwartz, M., & Drossman, D. (2014) · Current Gastroenterology Reports · doi:10.1007/s11894-014-0410-4 · Cited by 42
Saper, J. R., Lake, A. E., Bain, P. A., Stillman, M. J., Rothrock, J. F., Mathew, N. T., Hamel, R. L., Moriarty, M., & Tietjen, G. E. (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01733.x · Cited by 45
Montesinos, J., Gil, A., & Guerri, C. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13416 · Cited by 49
Opioid Analgesics Adverse Effects: The Other Side of the Coin
Mercadante, S. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190717152226 · Cited by 45
A Whole-Person Model of Care for Persistent Pain: From Conceptual Framework to Practical Application
Hayes, C., & Hodson, F. J. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01267.x · Cited by 45
Franklin, K. M., Hauser, S. R., Lasek, A. W., McClintick, J., Ding, Z.-M., McBride, W. J., & Bell, R. L. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3852-3 · Cited by 44
Tumati, S., Largent‐Milnes, T. M., Keresztes, A. I., Ren, J., Roeske, W. R., Vanderah, T. W., & Varga, E. V. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.12.021 · Cited by 45
Das, V., Kc, R., Li, X., Varma, D., Qiu, S., Kroin, J. S., Forsyth, C. B., Keshavarzian, A., van Wijnen, A. J., Park, T. J., et al. (2018) · Gene · doi:10.1016/j.gene.2018.02.048 · Cited by 42
Dose Escalation During the First Year of Long-Term Opioid Therapy for Chronic Pain
Henry, S. G., Wilsey, B. L., Melnikow, J. A., & Iosif, A. (2014) · Pain Medicine · doi:10.1111/pme.12634 · Cited by 41
Repeated Morphine Prolongs Postoperative Pain in Male Rats
Grace, P. M., Galer, E. L., Strand, K. A., Corrigan, K., Berkelhammer, D. L., Maier, S. F., & Watkins, L. R. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003345 · Cited by 43
Self-citationAceves, M., Terminel, M. N., Okoreeh, A. K., Aceves, A. R., Gong, Y. M., Polanco, A., Sohrabji, F., & Hook, M. A. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.023 · Cited by 41
Analgesic tolerance to morphine is regulated by PPAR γ
de Guglielmo, G., Kallupi, M., Scuppa, G., Stopponi, S., Demopulos, G. A., Gaitanaris, G., & Ciccocioppo, R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12851 · Cited by 41
Could glial activation be a factor in migraine?
Bartley, J. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.09.048 · Cited by 41
Microglia in neuroimmunopharmacology and drug addiction
Li, H., Watkins, L. R., & Wang, X. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02443-6 · Cited by 44
Self-citationHypothalamic opioid–Melanocortin appetitive balance and addictive craving
Reece, A. S. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.09.002 · Cited by 40
Opioid-Induced Hyperalgesia: Is It Clinically Relevant for the Treatment of Pain Patients?
Raffa, R. B., & Pergolizzi, J. V. (2011) · Pain Management Nursing · doi:10.1016/j.pmn.2011.04.002 · Cited by 40
Post herpetic neuralgia, schwann cell activation and vitamin D
Bartley, J. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.06.039 · Cited by 39
Sun, J., Liu, S., Mata, M. M., Fink, D. J., & Hao, S. (2011) · Gene Therapy · doi:10.1038/gt.2011.76 · Cited by 38
Hansson, E., Westerlund, A., Björklund, U., & Olsson, T. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.027 · Cited by 39
Toll-like receptor 4 signaling: A common biological mechanism of regimen-related toxicities
Wardill, H. R., Sebille, Y. Z. A. V., Mander, K. A., Gibson, R. J., Logan, R. M., Bowen, J. M., & Sonis, S. T. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.11.005 · Cited by 37
Saper, J. R., & Lake, A. E. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01153.x · Cited by 37
An Introduction to Pain Pathways and Pain “Targets”
Das, V. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.01.003 · Cited by 44
Fibromyalgia: Is it a Neuropathic Pain?
Cheng, C. W., Wong, C. S., Hui, G. K., Chung, E. K., & Wong, S. H. (2018) · Pain Management · doi:10.2217/pmt-2018-0024 · Cited by 36
Mannelli, P., Peindl, K., Lee, T., Bhatia, K. S., & Wu, L.-T. T. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205010052 · Cited by 38
Helley, M., Abate, W., Jackson, S. K., Bennett, J. H., & Thompson, S. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.069 · Cited by 35
Aguado, D., de Abreu, M. B., Benito, J., Fernandez, F., & de Segura, I. Á. G. (2013) · Anesthesiology · doi:10.1097/aln.0b013e3182887526 · Cited by 35
Delta opioid agonists: a concise update on potential therapeutic applications
Peppin, J. F., & Raffa, R. B. (2015) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12244 · Cited by 36
Sukhtankar, D. D., Lee, H., Rice, K. C., & Ko, M. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3341-0 · Cited by 35
Self-citationEmery, M. A., & Eitan, S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.010 · Cited by 36
Diasso, P. D. K., Birke, H., Nielsen, S. D., Main, K. M., Højsted, J., Sjøgren, P., & Kurita, G. P. (2019) · European Journal of Pain · doi:10.1002/ejp.1506 · Cited by 35
Hameed, H., Hameed, M., & Christo, P. J. (2010) · Current Pain and Headache Reports · doi:10.1007/s11916-010-0093-y · Cited by 34
Chen, J., Huang, K.-M., Liu, M., Jiang, J., Liu, J.-P., Zhang, Y.-X., Chen, Y., Xin, W., & Zhang, X. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.08.022 · Cited by 33
Lu, C., Ye, F., Luo, Q., Tao, Y., & Shu, H. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002601 · Cited by 33
Analgesic efficacy of laser acupuncture and electroacupuncture in cats undergoing ovariohysterectomy
Nascimento, F. F., Marques, V. I. M., Crociolli, G. C., Nicácio, G. M., Nicácio, I. P. G. A., & Cassu, R. N. (2019) · Journal of Veterinary Medical Science · doi:10.1292/jvms.18-0744 · Cited by 33
Medications Development for Opioid AbusePreprint
Negus, S. S., & Banks, M. L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012104 · Cited by 34
Ouyang, H., Liu, S., Zeng, W., Levitt, R. C., Candiotti, K. A., & Hao, S. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/940613 · Cited by 31
Weir, G. A., & Cader, M. Z. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-116 · Cited by 30
Shen, J., Fox, L. E., & Cheng, J. (2012) · Anesthesiology · doi:10.1097/aln.0b013e318260de41 · Cited by 29
Bajo, M., Madamba, S. G., Roberto, M., & Siggins, G. R. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2014.00045 · Cited by 29
Predictive factors of daily opioid use and quality of life in adults with sickle cell disease
Karafin, M. S., Singavi, A. K., Hussain, J. S., Wandersee, N. J., Heinrich, T. W., Hurley, R. W., Zhang, L., Simpson, P. M., & Field, J. J. (2018) · Hematology · doi:10.1080/10245332.2018.1479997 · Cited by 29
Morphine Preconditioning Protects Against LPS-Induced Neuroinflammation and Memory Deficit
Rostami, F., Oryan, S., Ahmadiani, A., & Dargahi, L. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9726-4 · Cited by 29
Cooper, Z. D., Johnson, K. W., Vosburg, S. K., Sullivan, M. A., Manubay, J. M., Martínez, D., Jones, J. D., Saccone, P. A., & Comer, S. D. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.04.029 · Cited by 28
Self-citationLow-dose Naltrexone Improves post–COVID-19 condition Symptoms
Tamariz, L. J., Bast, E. S., Klimas, N. G., & Palacio, A. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.12.009 · Cited by 27
Deng, X., Han, Y., Liu, W., & Song, X. (2017) · Pain Medicine · doi:10.1093/pm/pnw358 · Cited by 27
Li, W., Irvine, K., Sahbaie, P., Guo, T., Shi, X., Tawfik, V. L., Kingery, W. S., & Clark, J. D. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002495 · Cited by 27
Mustafa, S., Bajic, J. E., Barry, B., Evans, S. G., Siemens, K. R., Hutchinson, M. R., & Grace, P. M. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109459 · Cited by 31
Self-citationAceves, M., Mathai, B., & Hook, M. A. (2016) · Spinal Cord · doi:10.1038/sc.2016.28 · Cited by 26
Bland, S. T., Beckley, J. T., Watkins, L. R., Maier, S. F., & Bilbo, S. D. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.006 · Cited by 27
Self-citationShao, J., Wang, J., Huang, J., Liu, C., Pan, Y., Guo, Q., & Zou, W. (2018) · Molecular Brain · doi:10.1186/s13041-018-0365-8 · Cited by 26
Shafie, A., Moradi, F., Izadpanah, E., Mokarizadeh, A., Moloudi, M. R., Nikzaban, M., & Hassanzadeh, K. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.027 · Cited by 26
The Effects of Minocycline or Riluzole Treatment on Spinal Root Avulsion–Induced Pain in Adult Rats
Chew, D. J., Carlstedt, T. P., & Shortland, P. J. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.03.001 · Cited by 25
Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review
Woodcock, E. A., Hillmer, A. T., Mason, G. F., & Cosgrove, K. (2019) · Complex Psychiatry · doi:10.1159/000499621 · Cited by 27
Ghavimi, H., Charkhpour, M., Ghasemi, S., Abbasi, M. M., Hamishehkar, H., Hassanzadeh, K., Arami, S., & Hassanzadeh, K. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.08.003 · Cited by 25
Jones, J. D., Sullivan, M. A., Manubay, J. M., Mogali, S., Metz, V. E., Ciccocioppo, R., & Comer, S. D. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.10.006 · Cited by 24
Burns, L. H., & Wang, H.-Y. (2010) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s4870 · Cited by 24
The Immune System and the Developing Brain
Schwarz, J. M., & Bilbo, S. D. (2011) · Colloquium Series on The Developing Brain · doi:10.4199/c00045ed1v01y201110dbr004 · Cited by 25
Johnson, J. L., Kwok, Y. H., Sumracki, N. M., Swift, J. E., Hutchinson, M. R., Johnson, K. W., Williams, D. B., Tuke, J., & Rolan, P. E. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12655 · Cited by 24
Self-citationSchwandt, M. L., Diazgranados, N., Umhau, J. C., Kwako, L. E., George, D. T., & Heilig, M. A. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05540-w · Cited by 27
Gerhold, K. J., Drdla-Schutting, R., Honsek, S. D., Forsthuber, L., & Sandkühler, J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0731-14.2015 · Cited by 23
Li, Q. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.021 · Cited by 23
Rieb, L. M., Norman, W. V., Martin, R. E., Berkowitz, J., Wood, E., McNeil, R., & Milloy, M. (2016) · Pain · doi:10.1097/j.pain.0000000000000710 · Cited by 22
PTI-609: A Novel Analgesic that Binds Filamin A to Control Opioid Signaling
Burns, L. H., & Wang, H.-Y. (2010) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910793362386 · Cited by 22
New opioid side effects and implications for long-term therapy
Raghavan, S., Harvey, A., & Humble, S. R. (2010) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.cacc.2010.06.003 · Cited by 24
Smiley, C. E., & Wood, S. K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108212 · Cited by 24
Auvity, S., Saba, W., Goutal, S., Leroy, C., Buvat, I., Cayla, J., Caillé, F., Bottlaender, M., Cisternino, S., & Tournier, N. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw077 · Cited by 22
Self‐Reported Prescription Drug Use for Pain and for Sleep and Incident Frailty
Cil, G., Park, J., & Bergen, A. W. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16214 · Cited by 22
Naltrexone treatment reverses astrocyte atrophy and immune dysfunction in self-harming macaques
Lee, K. M., Chiu, K. B., Didier, P. J., Baker, K. C., & MacLean, A. G. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.07.017 · Cited by 23
Swingler, M., Donadoni, M., Unterwald, E. M., Maggirwar, S. B., & Sariyer, I. K. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1597922 · Cited by 24
Darnall, B. D., Aickin, M. G., & Zwickey, H. L. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.06.003 · Cited by 21
Bhalla, S., Rapolaviciute, V., & Gulati, A. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.090 · Cited by 21
In vitro morphine metabolism by rat microglia
Togna, A. R., Antonilli, L., Dovizio, M., Salemme, A., Carolis, L. D., Togna, G. I., Patrignani, P., & Nencini, P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.019 · Cited by 21
Yang, C.-P., Cherng, C., Wu, C., Huang, H.-Y., Tao, P., Lee, S.-O., & Wong, C. (2013) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000020 · Cited by 21
Clifford, J. L., Fowler, M., Hansen, J. J., Cheppudira, B. P., Nyland, J. E., Salas, M. M., McGhee, L. L., Petz, L. N., & Averitt, D. L. (2014) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000403 · Cited by 20
Chronic Daily Headache: Mechanisms and Principles of Management
Voigt, A. W., & Gould, H. J. (2016) · Current Pain and Headache Reports · doi:10.1007/s11916-016-0542-3 · Cited by 20
Understanding Chronic Pain in a Lifestyle Context
Hayes, C., Naylor, R., & Egger, G. J. (2012) · American Journal of Lifestyle Medicine · doi:10.1177/1559827612439282 · Cited by 20
Targeting novel mechanisms of pain in sickle cell disease
Tran, H., Gupta, M., & Gupta, K. (2017) · Hematology · doi:10.1182/asheducation-2017.1.546 · Cited by 20
Hamidkhaniha, S., Bashiri, H., Omidi, A., Hosseini‐Chegeni, A., Tavangar, S. M., Sabouri, S., Montazeri, H., & Sahebgharani, M. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13090 · Cited by 20
Arezoomandan, R., Moradi, M., Attarzadeh-Yazdi, G., Tomaz, C. A. B., & Haghparast, A. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.06.011 · Cited by 19
Management of Patients With Orofacial Pain and Temporomandibular Disorders
Bouloux, G. F., Chou, J. C., DiFabio, V. E., Ness, G. M., Pérez, D., Mercuri, L. G., Chung, W. L., Klasser, G. D., Bender, S. D., Kraus, S. L., et al. (2024) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2024.03.018 · Cited by 19
Schroeder, J. R., Phillips, K. A., Epstein, D. H., Jobes, M. L., Furnari, M. A., Kennedy, A., Heilig, M. A., & Preston, K. L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4986-5 · Cited by 19
Opioid Adjuvant Strategy: Improving Opioid Effectiveness
Bihel, F. J. ‐. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.186 · Cited by 19
Glial cells modulate hippocampal synaptic plasticity in morphine dependent rats
ماهانی, آ. ا., Heysieattalab, S., Hosseinmardi, N., Janahmadi, M., Seyedaghamiri, F., & Khoshbouei, H. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.04.006 · Cited by 20
Effects of morphine on testosterone levels in rat C6 glioma cells: Modulation by anastrozole
Ceccarelli, I., Rossi, A., Maddalena, M., Weber, E., & Aloisi, A. M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21830 · Cited by 17
Taylor, R., Pergolizzi, J. V., Porreca, F., & Raffa, R. B. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.778973 · Cited by 16
Micheli, L., Lucarini, E., Nobili, S., Bartolucci, G., Pallecchi, M., Toti, A., Ferrara, V., Ciampi, C., Ghelardini, C., & Mannelli, L. D. C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221128091453 · Cited by 18
Metadata
- Authors
- Hutchinson, M. R., Bland, S. T., Johnson, K. W., Rice, K. C., Maier, S. F., & Watkins, L. R.
- Affiliations
- University of Colorado Boulder (US)
- Avigen Inc., Alameda, CA, USA
- National Institute on Drug Abuse (US)
- Corresponding author
- Hutchinson, Mark R.
- ORCID
- Venue
- The Scientific World JOURNAL
- Publisher
- Wiley
- Published
- 2007
- Volume
- 7
- Pages
- 98-111
- ISSN
- 1537-744X (ISSN-L)
- PMC
- PMC5901235
- OpenAlex
- W2103801183
- Cited by
- 359
- References
- 61
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 14 · 2023: 11 · 2022: 14 · 2021: 12 · 2020: 18 · 2019: 19 · 2018: 26 · 2017: 21 · 2016: 24 · 2015: 20 · 2014: 25 · 2013: 19 · 2012: 24
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- The Scientific World JOURNAL (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health (DA015642, DA017670, DE017782)
- National Health and Medical Research Council (DA015642, DA017670, DE017782)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- glial activation, TLR4, neuropathic pain, opioid analgesia, opioid tolerance, opioid use disorder, opioid reward, conditioned place preference, dopamine, nucleus accumbens, morphine
- MeSH terms
- Analgesics, Opioid, Animals, Humans, Neuroglia, Pain, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
